Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
Q3 2024 vs. Q2 2024
How the institutions holding Sunshine Biopharma Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 11 | 10 | −1 |
| Shares | 216.6K | 35.0K | −181.6K (−83.8%) |
| Value | $89.6K | $111.3K | +$21.7K (+24.2%) |
New holders (7)
Institutions that held Sunshine Biopharma Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nordwand Advisors, LLC | 500 | $1.59K | 0.00% |
| Jaffetilchin Investment Partners, LLC | 1 | $3 | 0.00% |
| Advisor Group Holdings, Inc. | 1 | $3 | 0.00% |
| Rise Advisors, LLC | 1 | $3 | 0.00% |
| Farther Finance Advisors, LLC | 1 | $3 | 0.00% |
| TD Waterhouse Canada Inc. | 1 | $3 | 0.00% |
| Federation des caisses Desjardins du Quebec | 1 | $3 | 0.00% |
Sold out (8)
Institutions that held Sunshine Biopharma Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 76,967 | $32.1K |
| XTX Topco Ltd | 44,008 | $18.4K |
| HRT Financial LP | 45,022 | $18.0K |
| Jane Street Group, LLC | 27,856 | $11.6K |
| Sabby Management, LLC | 20,000 | $8.35K |
| Qube Research & Technologies Ltd | 1,529 | $638 |
| Main Street Group, LTD | 3 | $1 |
| UBS Group AG | 1 | $0 |